Cargando…

Skin physiology and safety of microfocused ultrasound with visualization for improving skin laxity

PURPOSE: The efficacy of microfocused ultrasound with visualization (MFU-V; Ultherapy(®)) has been demonstrated in clinical studies and daily practice. However, data addressing skin physiology after MFU-V treatment are lacking. This observational evaluation was aimed to assess skin physiology before...

Descripción completa

Detalles Bibliográficos
Autores principales: Kerscher, Martina, Nurrisyanti, Arti Tania, Eiben-Nielson, Christine, Hartmann, Susanne, Lambert-Baumann, Judith
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6336023/
https://www.ncbi.nlm.nih.gov/pubmed/30666145
http://dx.doi.org/10.2147/CCID.S188586
_version_ 1783388000834551808
author Kerscher, Martina
Nurrisyanti, Arti Tania
Eiben-Nielson, Christine
Hartmann, Susanne
Lambert-Baumann, Judith
author_facet Kerscher, Martina
Nurrisyanti, Arti Tania
Eiben-Nielson, Christine
Hartmann, Susanne
Lambert-Baumann, Judith
author_sort Kerscher, Martina
collection PubMed
description PURPOSE: The efficacy of microfocused ultrasound with visualization (MFU-V; Ultherapy(®)) has been demonstrated in clinical studies and daily practice. However, data addressing skin physiology after MFU-V treatment are lacking. This observational evaluation was aimed to assess skin physiology before and after MFU-V treatment using noninvasive biophysical measurements. PATIENTS AND METHODS: Twenty-two female patients with moderate-to-severe skin sagging at the jawline and submental region on the Merz Aesthetics Scale obtained a single MFU-V treatment according to protocol. Skin function measurements focused on short-term effects up to 3 days and long-term effects up to 24 weeks after treatment. Skin temperature, transepidermal water loss, skin hydration, erythema, elasticity, and skin thickness and density were evaluated under standardized conditions. Pain was assessed using a validated numeric visual analog scale. RESULTS: Skin temperature remained in a physiologic range and no significant increase was noted at day 3 after MFU-V treatment. Transepidermal water loss, hydration, and erythema values were fairly stable and showed no significant differences at short- and long-term measurements vs baseline. At week 4 after a single MFU-V treatment, gross and net elasticity values were significantly decreased (P=0.003 and P=0.0001, respectively), followed by significantly increased values at week 12 (P=0.015, P=0.046) and week 24 (P=0.001, P=0.049). Edema due to MFU-V treatment resolved without sequelae. For all patients, pain diminished shortly after treatment. No adverse events occurred during the 24-week follow-up period. CONCLUSIONS: MFU-V treatment is well tolerated and it does not alter the epidermal barrier function or physiology of skin. Significant increase in the elasticity of skin was observed at 12 and 24 weeks after a single treatment, which reflects improvement in dermal tissue function. These short- and long-term effects are congruous with the mode of action of MFU-V due to a proven intrinsic tissue remodeling process.
format Online
Article
Text
id pubmed-6336023
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-63360232019-01-21 Skin physiology and safety of microfocused ultrasound with visualization for improving skin laxity Kerscher, Martina Nurrisyanti, Arti Tania Eiben-Nielson, Christine Hartmann, Susanne Lambert-Baumann, Judith Clin Cosmet Investig Dermatol Original Research PURPOSE: The efficacy of microfocused ultrasound with visualization (MFU-V; Ultherapy(®)) has been demonstrated in clinical studies and daily practice. However, data addressing skin physiology after MFU-V treatment are lacking. This observational evaluation was aimed to assess skin physiology before and after MFU-V treatment using noninvasive biophysical measurements. PATIENTS AND METHODS: Twenty-two female patients with moderate-to-severe skin sagging at the jawline and submental region on the Merz Aesthetics Scale obtained a single MFU-V treatment according to protocol. Skin function measurements focused on short-term effects up to 3 days and long-term effects up to 24 weeks after treatment. Skin temperature, transepidermal water loss, skin hydration, erythema, elasticity, and skin thickness and density were evaluated under standardized conditions. Pain was assessed using a validated numeric visual analog scale. RESULTS: Skin temperature remained in a physiologic range and no significant increase was noted at day 3 after MFU-V treatment. Transepidermal water loss, hydration, and erythema values were fairly stable and showed no significant differences at short- and long-term measurements vs baseline. At week 4 after a single MFU-V treatment, gross and net elasticity values were significantly decreased (P=0.003 and P=0.0001, respectively), followed by significantly increased values at week 12 (P=0.015, P=0.046) and week 24 (P=0.001, P=0.049). Edema due to MFU-V treatment resolved without sequelae. For all patients, pain diminished shortly after treatment. No adverse events occurred during the 24-week follow-up period. CONCLUSIONS: MFU-V treatment is well tolerated and it does not alter the epidermal barrier function or physiology of skin. Significant increase in the elasticity of skin was observed at 12 and 24 weeks after a single treatment, which reflects improvement in dermal tissue function. These short- and long-term effects are congruous with the mode of action of MFU-V due to a proven intrinsic tissue remodeling process. Dove Medical Press 2019-01-14 /pmc/articles/PMC6336023/ /pubmed/30666145 http://dx.doi.org/10.2147/CCID.S188586 Text en © 2019 Kerscher et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Kerscher, Martina
Nurrisyanti, Arti Tania
Eiben-Nielson, Christine
Hartmann, Susanne
Lambert-Baumann, Judith
Skin physiology and safety of microfocused ultrasound with visualization for improving skin laxity
title Skin physiology and safety of microfocused ultrasound with visualization for improving skin laxity
title_full Skin physiology and safety of microfocused ultrasound with visualization for improving skin laxity
title_fullStr Skin physiology and safety of microfocused ultrasound with visualization for improving skin laxity
title_full_unstemmed Skin physiology and safety of microfocused ultrasound with visualization for improving skin laxity
title_short Skin physiology and safety of microfocused ultrasound with visualization for improving skin laxity
title_sort skin physiology and safety of microfocused ultrasound with visualization for improving skin laxity
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6336023/
https://www.ncbi.nlm.nih.gov/pubmed/30666145
http://dx.doi.org/10.2147/CCID.S188586
work_keys_str_mv AT kerschermartina skinphysiologyandsafetyofmicrofocusedultrasoundwithvisualizationforimprovingskinlaxity
AT nurrisyantiartitania skinphysiologyandsafetyofmicrofocusedultrasoundwithvisualizationforimprovingskinlaxity
AT eibennielsonchristine skinphysiologyandsafetyofmicrofocusedultrasoundwithvisualizationforimprovingskinlaxity
AT hartmannsusanne skinphysiologyandsafetyofmicrofocusedultrasoundwithvisualizationforimprovingskinlaxity
AT lambertbaumannjudith skinphysiologyandsafetyofmicrofocusedultrasoundwithvisualizationforimprovingskinlaxity